Endocrinology, Vol 130, 2135-2138, Copyright © 1992 by Endocrine Society

ARTICLES

Role of amino acids 261-418 in proteolytic cleavage of the extracellular region of the human thyrotropin receptor

D Russo, Y Nagayama, GD Chazenbalk, HL Wadsworth and B Rapoport
Thyroid Molecular Biology Unit, Veterans Administration Medical Center, San Francisco, California.

Previous in vivo cross-linking studies of TSH to the recombinant TSH receptor revealed that the receptor exists at least in part as a single chain glycoprotein of approximately about 100 kilodaltons (kDa), with intramolecular disulfide bonds. TSH also binds to a 54-kDa amino- terminal fragment of the TSH receptor (cleaved up-stream of amino acid residue 317). In the present study in order to better understand the structure of the TSH receptor, we covalently cross-linked radiolabeled TSH to six TSH-LH receptor extracellular region chimeras and the wild- type TSH receptor expressed on Chinese hamster ovary cells in vivo. In these chimeras, different regions of the TSH receptor were substituted with the homologous regions of the LH receptor. When analyzed under nonreducing conditions by polyacrylamide gel electrophoresis, the TSH- cross-linked products were similar to all TSH-LH receptor chimeras and the wild-type receptor. In contrast, differences among the receptors were noted when the TSH-cross-linked products were examined under reducing conditions. With the exception of two chimeras, as noted previously with the wild-type receptor, two TSH-cross-linked products were observed, representing TSH cross-linked to a holoreceptor of about approximately 100 kDa and a fragment of the receptor of about approximately 54 kDa. However, in the two chimeras in which both domains D and E (amino acids 261-418) of the TSH receptor were substituted, only the holoreceptor and not the smaller fragment was detected. Substitution of domains ABC (amino acids 1-260) did not prevent proteolytic cleavage of the TSH receptor. In conclusion, amino acids 261-418 are necessary for proteolytic cleavage of the extracellular region of the human TSH receptor.

This article has been cited by other articles:

				C.-R. Chen, G. D. Chazenbalk, K. A. Wawrowsky, S. M. McLachlan, and B. Rapoport Evidence that Human Thyroid Cells Express Uncleaved, Single-Chain Thyrotropin Receptors on Their Surface Endocrinology, June 1, 2006; 147(6): 3107 - 3113. [Abstract] [Full Text] [PDF]

				C.-R. Chen, G. D. Chazenbalk, S. M. McLachlan, and B. Rapoport Evidence that the C Terminus of the A Subunit Suppresses Thyrotropin Receptor Constitutive Activity Endocrinology, September 1, 2003; 144(9): 3821 - 3827. [Abstract] [Full Text] [PDF]

				C. H. Na, M. H. Lee, B. Y. Cho, and C.-B. Chae A Method for Identification of the Peptides That Bind to a Clone of Thyroid-Stimulating Antibodies in the Serum of Graves' Disease Patients J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1570 - 1576. [Abstract] [Full Text] [PDF]

				K. Tanaka, G. D. Chazenbalk, S. M. McLachlan, and B. Rapoport Subunit Structure of Thyrotropin Receptors Expressed on the Cell Surface J. Biol. Chem., November 26, 1999; 274(48): 33979 - 33984. [Abstract] [Full Text] [PDF]

				K. Tanaka, G. D. Chazenbalk, S. M. McLachlan, and B. Rapoport Thyrotropin Receptor Cleavage at Site 1 Involves Two Discontinuous Segments at Each End of the Unique 50-Amino Acid Insertion J. Biol. Chem., January 22, 1999; 274(4): 2093 - 2096. [Abstract] [Full Text] [PDF]

				B. Rapoport, G. D. Chazenbalk, J. C. Jaume, and S. M. McLachlan The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies Endocr. Rev., December 1, 1998; 19(6): 673 - 716. [Abstract] [Full Text]

				K. Tanaka, G. D. Chazenbalk, S. M. McLachlan, and B. Rapoport Thyrotropin Receptor Cleavage at Site 1 Does Not Involve a Specific Amino Acid Motif but Instead Depends on the Presence of the Unique, 50 Amino Acid Insertion J. Biol. Chem., January 23, 1998; 273(4): 1959 - 1963. [Abstract] [Full Text] [PDF]

				A. Kakinuma, G. D. Chazenbalk, K. Tanaka, Y. Nagayama, S. M. McLachlan, and B. Rapoport An N-Linked Glycosylation Motif from the Noncleaving Luteinizing Hormone Receptor Substituted for the Homologous Region (Gly367 to Glu369) of the Thyrotropin Receptor Prevents Cleavage at Its Second, Downstream Site J. Biol. Chem., November 7, 1997; 272(45): 28296 - 28300. [Abstract] [Full Text] [PDF]

				A. Martin, M. Nakashima, A. Zhou, D. Aronson, A. J. Werner, and T. F. Davies Detection of Major T Cell Epitopes on Human Thyroid Stimulating Hormone Receptor by Overriding Immune Heterogeneity in Patients with Graves' Disease J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3361 - 3366. [Abstract] [Full Text] [PDF]

				G. D. Chazenbalk, K. Tanaka, Y. Nagayama, A. Kakinuma, J. C. Jaume, S. M. McLachlan, and B. Rapoport Evidence That the Thyrotropin Receptor Ectodomain Contains Not One, But Two, Cleavage Sites Endocrinology, July 1, 1997; 138(7): 2893 - 2899. [Abstract] [Full Text] [PDF]

				J. Couet, S. Sar, A. Jolivet, M.-T. V. Hai, E. Milgrom, and M. Misrahi Shedding of Human Thyrotropin Receptor Ectodomain J. Biol. Chem., February 23, 1996; 271(8): 4545 - 4552. [Abstract] [Full Text] [PDF]

				R. Latif, P. Graves, and T. F. Davies Oligomerization of the Human Thyrotropin Receptor. FLUORESCENT PROTEIN-TAGGED hTSHR REVEALS POST-TRANSLATIONAL COMPLEXES J. Biol. Chem., November 21, 2001; 276(48): 45217 - 45224. [Abstract] [Full Text] [PDF]